Vivek Subbiah: Super thrilled to deliver the keynote lecture on “Precision Oncology: Future is now” at the Binaytara Foundation.

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, recently shared on X/Twitter:

“Welcome to Nashville.
Super thrilled to deliver the keynote lecture on Sunday, Sep 17th, at 8:15 am on “Precision Oncology: Future is now” at the Binaytara Foundation Hemesummit23! Thanks to the amazing “N’s” of the Heme world for organizing the meeting and for the invite Navneet Majhail, Nitin Jain, Naveen Pemmaraju & biNay.
Precision Medicine is tumor-agnostic for both solid and heme malignancies.
As a solid tumor doctor, it’s always exciting to collaborate & learn from our amazing hematology doctors.”

Source: Vivek Subbiah/Twitter